Lavkesh Bhute, Sayali Dighe, Oly Katari, Vivek Yadav, Sanyog Jain. Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer. // AAPS PharmSciTech. – 2024. – DOI: 10.1208/s12249-024-02988-3. – URL: https://doi.org/10.1208/s12249-024-02988-3
Lavkesh Bhute, Sayali Dighe, Oly Katari, Vivek Yadav, & Sanyog Jain (2024). Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer. AAPS PharmSciTech. https://doi.org/10.1208/s12249-024-02988-3
Lavkesh Bhute, et al. “Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer.” AAPS PharmSciTech, 2024. doi:10.1208/s12249-024-02988-3.
@article{Bhute2024,
title = {Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer},
author = {Bhute, Lavkesh and Dighe, Sayali and Katari, Oly and Yadav, Vivek and Jain, Sanyog},
journal = {AAPS PharmSciTech},
year = {2024},
doi = {10.1208/s12249-024-02988-3},
url = {https://doi.org/10.1208/s12249-024-02988-3}
}